In vitro, the extract inhibited proliferation of F-98 GBM cells in a dose-dependent manner, associated with the inhibition of AKT, glycogen synthase kinase 3 (GSK-3) phosphorylation and NF-κB. The gene discussed is AKT1; the disease is glioblastoma.